HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...

Bristol Myers Squibb's growth drugs rose 17% in the first nine months of 2025, helping offset a 16% legacy drug sales decline ...

As with every Hometown Hero, the process begins with a nomination and a vetting period before WBKO produces the segment.

Avery Dennison is set to announce its fourth-quarter results soon, with analysts projecting single-digit growth in its bottom ...

On Wednesday, AstroNova (NASDAQ:ALOT) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below.

As the international food and beverage sector continues to adapt to the accelerating demand for nutritious, allergen-friendly pantry staples, Beijing Shipuller Co., Ltd. has officially introduced an ...

Altria Group, Inc. presents compelling turnaround opportunity for 2026, driven by leadership transition & regulatory wins.

Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, ...

At the start of 2025, a study by The Beer Institute revealed that 60% of Americans saw nonalcoholic beer as a viable ...

Maddow describes Walmart like an “implicit contract” with the American shopper. Walmart builds the massive logistics machine, ...

After a decade of runaway growth, Tequila is growing up. In 2026, slowing consumer demand, transparency, and industry ...

Nvidia’s $20 billion strategic licensing deal with Groq represents one of the first clear moves in a four-front fight over ...